Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei-Chuen Tan-Koi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
European Journal of Human Genetics : EJHG|September 1, 2016
Role of pharmacogenetics in public health and clinical health care: a SWOT analysisRitika Kapoor, Wei Chuen Tan-Koi, Yik-Ying Teo
Vaccines|January 28, 2026
Regulatory Strengthening as a Pillar of Health System Resilience for Sustainable ImmunizationWei Chuen Tan-Koi, Yoong Khean Khoo, John Cw Lim
Pharmacoepidemiology and Drug Safety|May 14, 2016
Pharmacovigilance activities in ASEAN countriesWimon Suwankesawong, Teerapon Dhippayom, Wei-Chuen Tan-Koi, et al.
Pharmacogenomics|March 18, 2020
Is HLA-B*58:01 genotyping cost effective in guiding allopurinol use in gout patients with chronic kidney disease?Gim Gee Teng, Wei-Chuen Tan-Koi, Di Dong, et al.
Pharmacogenomics|November 12, 2015
Cost-effectiveness analysis of genotyping for HLA-B*5801 and an enhanced safety program in gout patients starting allopurinol in SingaporeDi Dong, Wei-Chuen Tan-Koi, Gim Gee Teng, et al.
Pharmacogenomics|June 28, 2016
A cluster of Epoetin-associated pure red cell aplasia: clinical features and the possible association of HLA-DRB1*12:02Chuen Wen Tan, Wei-Chuen Tan-Koi, Jennifer Ng, et al.
Drug Safety|December 11, 2023
Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision MakingYoong Khean Khoo, John C W Lim, Wei Chuen Tan-Koi, et al.
Vaccine|August 22, 2025
Regulatory factors affecting sustainable vaccine manufacturing in Asia and the Pacific: Findings from a scoping review and semi-structured interviewsMei Xuan Jessalyn Chan, Yoong Khean Khoo, Anne-Claire Stona, et al.
Vaccine|April 12, 2025
Regional cooperation on pandemic preparedness and vaccine equity from an economic, regulatory and legal perspectiveMei Xuan Jessalyn Chan, Olivier J Wouters, Hui Yun Chan, et al.
Pharmacogenomics|June 9, 2017
Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approachWei Chuen Tan-Koi, Cynthia Sung, Yong Yeow Chong, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
European Journal of Human Genetics : EJHG|September 1, 2016
Role of pharmacogenetics in public health and clinical health care: a SWOT analysisRitika Kapoor, Wei Chuen Tan-Koi, Yik-Ying Teo
Vaccines|January 28, 2026
Regulatory Strengthening as a Pillar of Health System Resilience for Sustainable ImmunizationWei Chuen Tan-Koi, Yoong Khean Khoo, John Cw Lim
Pharmacoepidemiology and Drug Safety|May 14, 2016
Pharmacovigilance activities in ASEAN countriesWimon Suwankesawong, Teerapon Dhippayom, Wei-Chuen Tan-Koi, et al.
Pharmacogenomics|March 18, 2020
Is HLA-B*58:01 genotyping cost effective in guiding allopurinol use in gout patients with chronic kidney disease?Gim Gee Teng, Wei-Chuen Tan-Koi, Di Dong, et al.
Pharmacogenomics|November 12, 2015
Cost-effectiveness analysis of genotyping for HLA-B*5801 and an enhanced safety program in gout patients starting allopurinol in SingaporeDi Dong, Wei-Chuen Tan-Koi, Gim Gee Teng, et al.
Pharmacogenomics|June 28, 2016
A cluster of Epoetin-associated pure red cell aplasia: clinical features and the possible association of HLA-DRB1*12:02Chuen Wen Tan, Wei-Chuen Tan-Koi, Jennifer Ng, et al.
Drug Safety|December 11, 2023
Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision MakingYoong Khean Khoo, John C W Lim, Wei Chuen Tan-Koi, et al.
Vaccine|August 22, 2025
Regulatory factors affecting sustainable vaccine manufacturing in Asia and the Pacific: Findings from a scoping review and semi-structured interviewsMei Xuan Jessalyn Chan, Yoong Khean Khoo, Anne-Claire Stona, et al.
Vaccine|April 12, 2025
Regional cooperation on pandemic preparedness and vaccine equity from an economic, regulatory and legal perspectiveMei Xuan Jessalyn Chan, Olivier J Wouters, Hui Yun Chan, et al.
Pharmacogenomics|June 9, 2017
Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approachWei Chuen Tan-Koi, Cynthia Sung, Yong Yeow Chong, et al.
Pageof 1